Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase S01.257: kallikrein-related peptidase 11

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Literature Substrates Pharma

(Topics flags: A Assay, P Specificity, R Splicing, K Knockout, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2023
  1. Gong,Z., Dai,S., Jiang,X., Lee,M., Zhu,X., Wang,H. and Lin,Z.
    Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder
    Br J Dermatol188, 100-111. PubMed  Europe PubMed DOI
  2. Stuardo-Parada,A., Lopez-Munoz,R., Villarroel-Espindola,F., Figueroa,C.D. and Ehrenfeld,P.
    Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
    Med Oncol40, 224-224. PubMed  Europe PubMed DOI  V
    3. 2021
  3. Zhao,R., Wang,S., Liu,J., Xu,C., Zhang,S., Shao,Y. and Duan,X.
    KLK11 acts as a tumor-inhibitor in laryngeal squamous cell carcinoma through the inactivation of Akt/Wnt/beta-catenin signaling
    J Bioenerg Biomembr53, 85-96. PubMed  Europe PubMed DOI  K
    4. 2019
  4. He,X., Meng,F., Qin,L., Liu,Z., Zhu,X., Yu,Z. and Zheng,Y.
    KLK11 suppresses cellular proliferation via inhibition of Wnt/beta-catenin signaling pathway in esophageal squamous cell carcinoma
    Am J Cancer Res9, 2264-2277. PubMed  Europe PubMed
    5. 2018
  5. Adamopoulos,P.G., Kontos,C.K. and Scorilas,A.
    Novel splice variants of the human kallikrein-related peptidases 11 (KLK11) and 12 (KLK12), unraveled by Next-Generation Sequencing technology
    Biol Chem399, 1065-1071. PubMed  Europe PubMed DOI  R
    6. 2016
  6. Karakosta,T.D., Soosaipillai,A., Diamandis,E.P., Batruch,I. and Drabovich,A.P.
    Quantification of human kallikrein-related peptidases in biological fluids by multiplatform targeted mass spectrometry assays
    Mol Cell Proteomics15, 2863-2876. PubMed  Europe PubMed DOI  A
    7. 2015
  7. Angelopoulou,K. and Karagiannis,G.S.
    Identification, molecular characterization and alternative splicing of three novel members of the canine kallikrein (Klk)-related peptidase family
    Anticancer Res35, 2715-2723. PubMed  Europe PubMed
    8. 2013
  8. Lundwall,A.
    Old genes and new genes: The evolution of the kallikrein locus
    Thromb Haemost110, 469-475. PubMed  Europe PubMed DOI  V
    9. 2012
  9. Clements,J.A., Hooper,J.D. and Dong,Y.
    The human tissue kallikrein and kallikrein-related peptidase family
    [ISSN:978-0-12-407742-3]3, 2747-2756. DOI
  10. Yamaguchi,N.
    Human kallikrein 11 or hippostasin
    [ISSN:978-0-12-407742-3]3, 2802-2805. DOI
    11. 2008
  11. Clements,J.A.
    Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
    Biol Chem389, 1447-1454. PubMed  Europe PubMed DOI  V
  12. Yoon,H., Blaber,S.I., Evans,D.M., Trim,J., Juliano,M.A., Scarisbrick,I.A. and Blaber,M.
    Activation profiles of human kallikrein-related peptidases by proteases of the thrombostasis axis
    Protein Sci17, 1998-2007. PubMed  Europe PubMed DOI
    13. 2007
  13. Fernando,S.C., Najar,F.Z., Guo,X., Zhou,L., Fu,Y., Geisert,R.D., Roe,B.A. and DeSilva,U.
    Porcine kallikrein gene family: genomic structure, mapping, and differential expression analysis
    Genomics89, 429-438. PubMed  Europe PubMed DOI
  14. McIntosh,M.W., Liu,Y., Drescher,C., Urban,N. and Diamandis,E.P.
    Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma
    Clin Cancer Res13, 4422-4428. PubMed  Europe PubMed DOI
  15. Sano,A., Sangai,T., Maeda,H., Nakamura,M., Hasebe,T. and Ochiai,A.
    Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3
    Int J Oncol30, 1493-1498. PubMed  Europe PubMed
  16. Yoon,H., Laxmikanthan,G., Lee,J., Blaber,S.I., Rodriguez,A., Kogot,J.M., Scarisbrick,I.A. and Blaber,M.
    Activation profiles and regulatory cascades of the human kallikrein-related peptidases
    J Biol Chem282, 31852-31864. PubMed  Europe PubMed DOI  V
    17. 2006
  17. [YEAR:1-6-2006]Debela,M., Magdolen,V., Schechter,N., Valachova,M., Lottspeich,F., Craik,C.S., Choe,Y., Bode,W. and Goettig,P.
    Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences
    J Biol Chem281, 25678-25688. PubMed  Europe PubMed DOI  P
  18. Luo,L.Y. and Jiang,W.
    Inhibition profiles of human tissue kallikreins by serine protease inhibitors
    Biol Chem387, 813-816. PubMed  Europe PubMed DOI
  19. [YEAR:1-2-2006]Luo,L.Y., Shan,S.J., Elliott,M.B., Soosaipillai,A. and Diamandis,E.P.
    Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma
    Clin Cancer Res12, 742-750. PubMed  Europe PubMed DOI
  20. Mitsui,S., Nakamura,T., Okui,A., Kominami,K., Uemura,H. and Yamaguchi,N.
    Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin
    FEBS J273, 3678-3686. PubMed  Europe PubMed DOI  R
    21. 2005
  21. [YEAR:25-5-2005]Kurlender,L., Borgono,C., Michael,I.P., Obiezu,C., Elliott,M.B., Yousef,G.M. and Diamandis,E.P.
    A survey of alternative transcripts of human tissue kallikrein genes
    Biochim Biophys Acta1755, 1-14. PubMed  Europe PubMed DOI  R
  22. [YEAR:11-5-2005]Stavropoulou,P., Gregorakis,A.K., Plebani,M. and Scorilas,A.
    Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer
    Clin Chim Acta357, 190-195. PubMed  Europe PubMed DOI
    23. 2004
  23. Clements,J.A., Hooper,J.D., Odorico,D.M. and Dong,Y.
    The tissue kallikrein gene cluster
    [ISSN:0-12-079610-4]2, 1569-1577.  V
  24. Diamandis,E.P., Borgono,C.A., Scorilas,A., Harbeck,N., Dorn,J. and Schmitt,M.
    Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients
    Clin Biochem37, 823-829. PubMed  Europe PubMed DOI
  25. [YEAR:15-4-2004]Shigemasa,K., Gu,L., Tanimoto,H., O'Brien,T.J. and Ohama,K.
    Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer
    Clin Cancer Res10, 2766-2770. PubMed  Europe PubMed DOI
  26. Yamaguchi,N.
    Human kallikrein 11 or hippostasin
    [ISSN:0-12-079610-4]2, 1595-1597.  V
    27. 2003
  27. [YEAR:10-9-2003]Borgono,C.A., Fracchioli,S., Yousef,G.M., Rigault de la Longrais,I.A., Luo,L.Y., Soosaipillai,A., Puopolo,M., Grass,L., Scorilas,A., Diamandis,E.P. and Katsaros,D.
    Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma
    Int J Cancer106, 605-610. PubMed  Europe PubMed DOI
  28. [YEAR:1-3-2003]Nakamura,T., Mitsui,S., Okui,A., Miki,T. and Yamaguchi,N.
    Molecular cloning and expression of a variant form of hippostasin/KLK11 in prostate
    Prostate54, 299-305. PubMed  Europe PubMed DOI  R
  29. Nakamura,T., Stephan,C., Scorilas,A., Yousef,G.M., Jung,K. and Diamandis,E.P.
    Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues
    Urology61, 1042-1046. PubMed  Europe PubMed DOI  R
  30. [YEAR:1-5-2003]Yousef,G.M., Polymeris,M.E., Yacoub,G.M., Scorilas,A., Soosaipillai,A., Popalis,C., Fracchioli,S., Katsaros,D. and Diamandis,E.P.
    Parallel overexpression of seven kallikrein genes in ovarian cancer
    Cancer Res63, 2223-2227. PubMed  Europe PubMed
    31. 2002
  31. [YEAR:1-1-2002]Diamandis,E.P., Okui,A., Mitsui,S., Luo,L.Y., Soosaipillai,A., Grass,L., Nakamura,T., Howarth,D.J. and Yamaguchi,N.
    Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma
    Cancer Res62, 295-300. PubMed  Europe PubMed  E
    32. 2001
  32. Clements,J., Hooper,J., Dong,Y. and Harvey,T.
    The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions
    Biol Chem382, 5-14. PubMed  Europe PubMed DOI  V
  33. [YEAR:15-9-2001]Nakamura,T., Mitsui,S., Okui,A., Kominami,K., Nomoto,T., Ukimura,O., Kawauchi,A., Miki,T. and Yamaguchi,N.
    Alternative splicing isoforms of hippostasin (PRSS20/KLK11) in prostate cancer cell lines
    Prostate49, 72-78. PubMed  Europe PubMed DOI  R
    34. 2000
  34. [YEAR:27-5-2000]Mitsui,S., Yamada,T., Okui,A., Kominami,K., Uemura,H. and Yamaguchi,N.
    A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate
    Biochem Biophys Res Commun272, 205-211. PubMed  Europe PubMed DOI  R
  35. [YEAR:15-11-2000]Mitsui,S., Okui,A., Kominami,K., Uemura,H. and Yamaguchi,N.
    cDNA cloning and tissue-specific splicing variants of mouse hippostasin/TLSP (PRSS20)
    Biochim Biophys Acta1494, 206-210. PubMed  Europe PubMed
  36. [YEAR:1-1-2000]Yousef,G.M., Scorilas,A. and Diamandis,E.P.
    Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family
    Genomics63, 88-96. PubMed  Europe PubMed DOI
    37. 1998
  37. Yoshida,S., Taniguchi,M., Suemoto,T., Oka,T., He,X. and Shiosaka,S.
    cDNA cloning and expression of a novel serine protease, TLSP
    Biochim Biophys Acta1399, 225-228. PubMed  Europe PubMed DOI

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use